Biopharma Trends 2018: Towards Industry 4.0
Attending
CPI’s, Lucy Foley, Director of Biologics is speaking at the Biopharma Trends 2018: Towards Industry 4.0 conference.
Industry 4.0 represents the adoption of intelligent, data-driven approaches to manufacturing that are already bringing tangible advantages to other sectors.
But what about biopharma? Is Industry 4.0 all-empowering or all hype?
At Biopharma Trends 2018: Towards Industry 4.0, international experts from The Medicine Maker Power List, NIBRT, and the wider biopharmaceutical industry will come together to debate the feasibility of Industry 4.0 – and discuss elements of the fourth industrial revolution that are already making a mark on biopharma manufacturing.